Cholangiocytic apoptosis in chronic ductopenic rejection

Human Pathology

Volumn 32, Issue 8, 2001, Pages 823-827

  Koukoulis, George K ^a   Shen, Jikun ^a   Karademir, Sedat ^a   Jensen, Donald ^a   Williams, James ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Hospital   (United States)

Author keywords

Apoptosis; Bile ducts; Liver; Rejection

Indexed keywords

PROTEIN BCL 2;

APOPTOSIS; ARTICLE; BILE DUCT; CLINICAL ARTICLE; GRAFT REJECTION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LIVER BIOPSY; LIVER TRANSPLANTATION; PATHOGENESIS; PROTEIN EXPRESSION;

EID: 0034876049     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2001.26465     Document Type: Article

References (25)

1. Apoptosis of bile duct epithelial cells in hepatic allograft rejection
2. An electron microscopic study of the mode of donor cell death in unmodified rejection of pig liver allografts
3. Electron microscopy of rejected human liver allografts
4. Apoptosis in the human liver during allograft rejection and end stage liver disease
5. The apoptosis protector, bcl- 2 protein is downregulated in bile duct epithelial cells of human liver allografts
6. Regulation of apoptosis by bcl-2 and its related proteins: Immunohistochemical challenges and therapeutic implications
7. Bcl- 2 protein is topographically restricted in tissues characterized by apoptotic cell death
8. Immunohistochemical detection of bcl- 2 protein in normal and pathologic liver
9. Immunolocalization of blc-2 and met oncoproteins in normal liver, cirrhosis and ductopenic rejection
10. Histopathologic features in sequential biopsies during the evolution of chronic (ductopenic) allograft rejection
11. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
12. Transplantation pathology, including liver injury in graft versus host disease and in recipients of renal and other allografts
13. Histometric and serial section observations of the intrahepatic bile ducts in primary biliary cirrhosis
14. The biology of biliary epithelia
15. New concepts in biliary cirrhosis
16. Working recommendations for the histopathologic staging and reporting of chronic rejection
17. A histometric analysis of chronically rejected human liver allografts: Insights into the mechanisms of bile duct loss: Direct immunologic and ischemic factors
18. Chronic liver allograft rejection and obliterative arteriopathy: Possible pathogenic mechanisms
19. Evidence that portal tract microvascular destruction precedes bile duct loss in human liver allograft rejection
20. Bile duct proliferation-its true significance?
21. A cytokeratin-immunohistochemical study of alcoholic liver disease: Evidence that hepatocytes can express "bile duct type" cytokeratins
22. A cytokeratin immunohistochemical study of cholestatic liver disease: Evidence that hepatocytes can express "bile duct type" cytokeratins
23. A cytokeratin immunohistochemical study of focal nodular hyperplasia: Further evidence that ductular metaplasia of hepatocytes contributes to ductular "proliferation"
24. Reactive biliary epithelium: The product of a pluripotential stem cell compartment?
25. The stem cell of the liver - A selective review